Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67(1), 328–357. https://doi.org/10.1002/hep.29367
Gastroenterological Society of Australia. (2023). Metabolic dysfunction-associated steatotic liver disease (MASLD). https://www.gesa.org.au/education/clinical-information/masld/
Kennedy, O. J., Roderick, P., Buchanan, R., Fallowfield, J. A., Hayes, P. C., & Parkes, J. (2016). Systematic review with meta-analysis: Coffee consumption and the risk of cirrhosis. Alimentary Pharmacology & Therapeutics, 43(5), 562–574. https://doi.org/10.1111/apt.13523
Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Boursier, J., Kamal-Bahl, S., Schattenberg, J. M., Anstee, QM., & NAFLD Nomenclature consensus group. (2023). A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology, 78(6), 1966-1986. https://doi.org/10.1097/HEP.0000000000000520
Romero-Gómez, M., Zelber-Sagi, S., & Trenell, M. (2017). Treatment of NAFLD with diet, physical activity and exercise. Journal of Hepatology, 67(4), 829–846. https://doi.org/10.1016/j.jhep.2017.05.016